Author: Bill Snyder
MEGAMicrobe event to explore world of microbes Sept. 17
Aug. 31, 2022—Families, parents, teachers, and students are invited to explore the world of microbes during a free hands-on event from 9 a.m.to 2 p.m. Saturday, Sept. 17, at the Warner Elementary Arts Magnet School, 626 Russell Street in East Nashville. Hosted by the Vanderbilt Institute for Infection, Immunology and Inflammation (VI4) in partnership with Nashville Parent...
Study describes how E. coli co-opts cells, causes recurrent UTIs
Aug. 25, 2022—Researchers at Vanderbilt University Medical Center have discovered why the uropathogenic bacterium E. coli, the leading cause of urinary tract infections, is so tenacious; their findings could lead to new ways to prevent recurrent UTIs.
Rheumatoid arthritis and heart disease: a common path
Aug. 25, 2022—An increase in certain antibodies in patients with rheumatoid arthritis can serve as a predictive biomarker for cardiovascular disease, Vanderbilt researchers have discovered.
COVID antibody research conducted at VUMC lands national award
Aug. 24, 2022—A long-acting antibody combination discovered at Vanderbilt University Medical Center that protects against COVID-19 in high-risk individuals has received a gold medal in the 2022 R&D 100 awards program announced Aug. 22 by R&D World Magazine.
Study seeks to explore drug link to fetal vessel defect
Aug. 18, 2022—Vanderbilt researchers have received a grant to study whether drugs given to premature infants in the neonatal intensive care unit (NICU) contribute to a potentially lethal condition called patent ductus arteriosus.
Vanderbilt Prize winner Lehmann’s Discovery Lecture postponed
Aug. 17, 2022—Ruth Lehmann, PhD, recipient of the 2022 Vanderbilt Prize in Biomedical Science, will deliver her Vanderbilt Prize Discovery Lecture at 4 p.m. Thursday, Sept. 1, in 208 Light Hall.
Nanoparticles boost anti-cancer immunity
Aug. 16, 2022—An ingenious targeted nanoparticle approach developed by Vanderbilt researchers reduced tumor burden in a model of ovarian cancer.
Science career “pipeline” garners national attention
Aug. 3, 2022—Vanderbilt's Aspirnaut STEM pipeline for diversity and wellness recently celebrated its 15th anniversary with a daylong scientific symposium, followed by a feature on the program broadcast Aug. 2 on NBC Nightly News.
Embryo screening for mental illness questioned
Aug. 3, 2022—Report finds polygenic embryo screening (PES) does not provide an accurate measure of the risk of developing psychiatric disorders later in life.
Video vital for telehealth visits
Jul. 28, 2022—Vanderbilt study of 18,130 telehealth visits at the beginning of the COVID-19 pandemic defines risk factors associated with telehealth access and suggests how health systems can improve access.
C. difficile may contribute to colorectal cancer: study
Jul. 28, 2022—A Vanderbilt study found that the bacterium Clostridioides difficile (C. difficile) may be a previously unrecognized contributor to colorectal cancer.
Difficulty swallowing linked to chronic opioid use: study
Jul. 21, 2022—Vanderbilt researchers found that chronic use of opioid painkillers like hydrocodone and oxycodone significantly increases the risk of dysphagia, or difficulty swallowing.
